Notice Type
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:


Product: Bridion
Active Ingredient: Sugammadex 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: NV Organon, Oss, Netherlands
Patheon Manufacturing Services LLC, North Carolina, United States of America
Product: RINVOQ
Active Ingredient: Upadacitinib hemihydrate 15.4mg equivalent to upadacitinib 15mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AbbVie Limited
Manufacturer: AbbVie Ireland NL B.V., Sligo, Ireland

Dated this 29th day of July 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).